103 related articles for article (PubMed ID: 2174735)
1. Effect of hexamethylene bisacetamide and cyclosporin A on recovery of herpes simplex virus type 2 from the in vitro model of latency in a human neuroblastoma cell line.
Kondo Y; Yura Y; Iga H; Yanagawa T; Yoshida H; Furumoto N; Sato M
Cancer Res; 1990 Dec; 50(24):7852-7. PubMed ID: 2174735
[TBL] [Abstract][Full Text] [Related]
2. Enhanced replication of herpes simplex virus by hexamethylene bisacetamide.
Yura Y; Kondo Y; Iga H; Harada K; Tujimoto H; Yanagawa T; Yoshida H; Sato M
J Natl Cancer Inst; 1991 Feb; 83(3):186-9. PubMed ID: 1846430
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of antitumor activity of herpes simplex virus gamma(1)34.5-deficient mutant for oral squamous cell carcinoma cells by hexamethylene bisacetamide.
Naito S; Obayashi S; Sumi T; Iwai S; Nakazawa M; Ikuta K; Yura Y
Cancer Gene Ther; 2006 Aug; 13(8):780-91. PubMed ID: 16645620
[TBL] [Abstract][Full Text] [Related]
4. Hexamethylene bisacetamide stimulates herpes simplex virus immediate early gene expression in the absence of trans-induction by Vmw65.
McFarlane M; Daksis JI; Preston CM
J Gen Virol; 1992 Feb; 73 ( Pt 2)():285-92. PubMed ID: 1371540
[TBL] [Abstract][Full Text] [Related]
5. Neuronal control of herpes simplex virus latency.
Tenser RB; Edris WA; Hay KA
Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of hexamethylene bisacetamide on replication of human cytomegalovirus.
Kitagawa R; Hagihara K; Uhara M; Matsutani K; Kirita A; Tanaka J
Arch Virol; 2005 Oct; 150(10):1977-91. PubMed ID: 15959837
[TBL] [Abstract][Full Text] [Related]
7. A latent infection of herpes simplex virus type 2 in a human neuroblastoma cell line IMR-32.
Yura Y; Terashima K; Iga H; Yanagawa T; Yoshida H; Hayashi Y; Sato M
Arch Virol; 1986; 90(3-4):249-60. PubMed ID: 3015082
[TBL] [Abstract][Full Text] [Related]
8. Lack of correlation between the expression of herpes simplex virus type 1 (HSV-1) glycoprotein C and both the maintenance of persistence in vitro and the capacity to establish latency in vivo.
Mannini-Palenzona A; Bartoletti AM; Mannini F; Cassai E; Tognon M
Microbiologica; 1988 Apr; 11(2):101-10. PubMed ID: 2841558
[TBL] [Abstract][Full Text] [Related]
9. The role of cyclic nucleotide mediators in latency and reactivation of HSV-1 infected neuroblastoma cells.
Rodriguez A; Sainz De La Maza M; Missry J; Foster CS
Eye (Lond); 1991; 5 ( Pt 5)():627-35. PubMed ID: 1665422
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
Jarnagin WR; Zager JS; Hezel M; Stanziale SF; Adusumilli PS; Gonen M; Ebright MI; Culliford A; Gusani NJ; Fong Y
Cancer Gene Ther; 2006 Mar; 13(3):326-34. PubMed ID: 16138120
[TBL] [Abstract][Full Text] [Related]
11. Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer.
Coukos G; Makrigiannakis A; Kang EH; Caparelli D; Benjamin I; Kaiser LR; Rubin SC; Albelda SM; Molnar-Kimber KL
Clin Cancer Res; 1999 Jun; 5(6):1523-37. PubMed ID: 10389942
[TBL] [Abstract][Full Text] [Related]
12. Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1.
Halford WP; Gebhardt BM; Carr DJ
Virology; 1997 Nov; 238(1):53-63. PubMed ID: 9375008
[TBL] [Abstract][Full Text] [Related]
13. The effect of herpes simplex virus type 1 L-particles on virus entry, replication, and the infectivity of naked herpesvirus DNA.
Dargan DJ; Subak-Sharpe JH
Virology; 1997 Dec; 239(2):378-88. PubMed ID: 9434728
[TBL] [Abstract][Full Text] [Related]
14. Cyclic nucleotide modulation of herpes simplex virus latency and reactivation.
Sainz de la Maza M; Wells PA; Foster CS
Invest Ophthalmol Vis Sci; 1989 Oct; 30(10):2154-9. PubMed ID: 2551836
[TBL] [Abstract][Full Text] [Related]
15. Suppression of HSV-1 infection in trigeminal ganglion cells. An in vitro model of latency.
Dunkel EC; Green MT; Rosborough JP
Invest Ophthalmol Vis Sci; 1984 May; 25(5):525-33. PubMed ID: 6325365
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
17. Macromolecular synthesis at the early stage of herpes simplex virus type 2 (HSV-2) latency in a human neuroblastoma cell line IMR-32: repression of late viral polypeptide synthesis and accumulation of cellular heat-shock proteins.
Yura Y; Terashima K; Iga H; Kondo Y; Yanagawa T; Yoshida H; Hayashi Y; Sato M
Arch Virol; 1987; 96(1-2):17-28. PubMed ID: 3039946
[TBL] [Abstract][Full Text] [Related]
18. Effects of differentiation of human macrophage-like U937 cells on intrinsic resistance to herpes simplex virus type 1.
Tenney DJ; Morahan PS
J Immunol; 1987 Nov; 139(9):3076-83. PubMed ID: 2822803
[TBL] [Abstract][Full Text] [Related]
19. [Effect of hexamethylene bisacetamide on human gastric cancer cell line SGC-7901].
Xu SW
Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):30-3. PubMed ID: 2194772
[TBL] [Abstract][Full Text] [Related]
20. Production and some properties of neutralizing antigens of herpes simplex virus.
Kutinová L; Vonka V; Rezácová D
Acta Virol; 1977 May; 21(3):189-97. PubMed ID: 18916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
